GlassScriptPhysician profile
Kevin C Lee
NPI 1407890973
$2,470.48
in general payments reported to CMS, 2019-2025
23 companies · $25.25 in 2025
The $25.25 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $161 · 2021: $316 · 2022: $1,144 · 2023: $286 · 2024: $36.10 · 2025: $25.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $669.08 | 2022 | |
| Alcon Vision LLC | $382.27 | 2019-2023 | Luxor, Verion |
| Depuy Synthes Sales INC. | $181.79 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $179.39 | 2019-2024 | Tecnis Iol, Tecnis Iol, Veritas Vision System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.26 | 2019-2021 | |
| Allergan, INC. | $110.48 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $85.77 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $81.53 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $80.09 | 2023-2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $77.64 | 2020-2021 | |
| Horizon Therapeutics Plc | $75.83 | 2022-2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $70.04 | 2023 | Acthar |
| Kala Pharmaceuticals, INC. | $64.69 | 2019-2021 | |
| Sight Sciences, INC. | $45.07 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $43.15 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $37.13 | 2019-2020 | |
| Biotissue Holdings INC. | $26.94 | 2022 | |
| Lilly USA, LLC | $25.25 | 2025 | Ebglyss, Taltz |
| Abbvie INC. | $23.00 | 2023 | |
| Procept Biorobotics Corporation | $19.65 | 2021 | |
| Alcon Research LLC | $18.65 | 2019 | |
| Shire North American Group INC | $18.45 | 2019 | |
| Bausch & Lomb Americas INC. | $18.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.